The Valley Desk

Clinical trial reportEuropean journal of nuclear medicine and molecular imagingPublished

Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
European journal of nuclear medicine and molecular imaging
Published
Subject terms
Humans; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Intestinal Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Adrenal Gland Neoplasms; Organometallic Compounds; Octreotide; Receptors, Somatostatin; Radiopharmaceuticals
PubMed ID
40198358
PubMed Central ID
PMC12397115
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal